Antibiotic Stewardship in Premature Infants: A Systematic Review

Polona Rajar1,2, Ola D Saugstad3, Dag Berild4,5

  • 1Department of Paediatrics, Oslo University Hospital Ullevål, Oslo, Norway.

Neonatology
|December 3, 2020
PubMed

Insights

Antibiotic stewardship programs effectively reduce antibiotic use in premature infants when tailored and multifactorial. Focused strategies on reducing initiation or duration of antibiotic therapy are key for success in neonatal intensive care units.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Antibiotic overuse in premature infants is common in neonatal intensive care units, leading to serious side effects and potential long-term adverse health outcomes.
  • Antibiotic stewardship programs (ASPs) are a preventive measure to reduce unnecessary antibiotic exposure in vulnerable infant populations.
  • This review focuses on ASPs implemented in premature infants with gestational age ≤34 weeks.

Approach:

  • A systematic literature search was conducted across six major academic databases, adhering to PRISMA guidelines.
  • Twelve studies (11 observational, 1 RCT) met the inclusion criteria after screening 1,212 titles.
  • Articles were critically appraised and grouped by stewardship action: reducing initiation, shortening duration, or organizational implementations.

Key Points:

  • Implemented ASPs demonstrated reductions in antibiotic use among premature newborns.
  • Multifactorial and tailored programs focusing on reducing antibiotic initiation or duration were most effective.
  • Programs lacking specific, targeted measures showed diminished effectiveness.

Conclusions:

  • Antibiotic stewardship programs are effective interventions for premature infants.
  • Tailored, multifactorial ASPs focusing on antibiotic initiation and duration are recommended for neonatal populations.
  • Targeted stewardship strategies are crucial for optimizing antibiotic use and improving outcomes in premature infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
112
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.9K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
112
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
793
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
89